...
首页> 外文期刊>Urology >Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
【24h】

Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.

机译:肾细胞癌患者14q24-31号染色体等位基因缺失与预后不良之间呈正相关。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To report our development of a new application of the inter-Alu long polymerase chain reaction (PCR) for genomic scanning to screen for tumor-specific alterations in tumor DNA. Using this method, we detected a rearranged chromosomal region in renal cell carcinomas (RCCs). We then examined tumor-specific allelic loss in this region using microsatellite markers and determined whether a relationship was present between this allelic loss and the clinicopathologic features of the patients. METHODS: The inter-Alu long PCR genomic scan method was performed using RCC DNA samples and primers specific for a minor subset of the human repeat sequence Alu. We analyzed DNA samples from 42 pairs of matched normal and nonpapillary RCC tissues with seven microsatellite markers. RESULTS: The inter-Alu long PCR genomic scan method revealed an altered DNA region on chromosome 14q24-31, which is the location of several putative tumor suppressor genes. At least one of seven microsatellite markers on chromosome 14q24-31 showed loss of heterozygosity in 23 (54.8%) of 42 informative cases of RCC. The prevalent loss region was confined to a 2-Mb region around D14S67. We found a positive correlation between the presence of the loss of heterozygosity on 14q24-31 and tumor stage (P <0.05). We also found that cases with allelic loss at 14q24-31 had a poor prognosis (P = 0.045). CONCLUSIONS: Our inter-Alu long PCR genomic scan method is a powerful method for the screening of DNA alterations, and our data suggest that the chromosome 14q24-31 region contains likely tumor suppressor genes associated with the progression of RCC.
机译:目的:报告我们在铝间长聚合酶链反应(PCR)在基因组扫描中筛选肿瘤DNA中肿瘤特异性改变的新应用的进展。使用这种方法,我们检测到肾细胞癌(RCCs)中的染色体区域重排。然后,我们使用微卫星标记检查了该区域的肿瘤特异性等位基因缺失,并确定该等位基因缺失与患者的临床病理特征之间是否存在关系。方法:使用RCC DNA样品和对人类重复序列Alu的一小部分特异的引物,进行Alu间长PCR基因组扫描方法。我们分析了来自42对匹配的正常和非乳头状RCC组织的DNA样品,这些组织具有7个微卫星标记。结果:Alu间长PCR基因组扫描方法揭示了14q24-31染色体上的DNA区域发生了改变,这是几个推定的抑癌基因的位置。在14q24-31染色体上的七个微卫星标记中,至少有一个在42例RCC病例中有23例(54.8%)显示杂合性丧失。普遍的损失区域被限制在D14S67周围的2-Mb区域。我们发现14q24-31杂合性缺失的存在与肿瘤分期之间呈正相关(P <0.05)。我们还发现在14q24-31时等位基因缺失的病例预后较差(P = 0.045)。结论:我们的Alu间长PCR基因组扫描方法是一种筛选DNA改变的有力方法,我们的数据表明,染色体14q24-31区域含有可能与RCC进程相关的抑癌基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号